{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T20:04:57Z","timestamp":1650744297983},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/cmr.0b013e3283632ca7","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T15:56:05Z","timestamp":1371743765000},"page":"336-339","source":"Crossref","is-referenced-by-count":2,"title":["Generalized lymphadenopathy mimicking malignant lymph node metastases after interferon-\u03b12b therapy for melanoma"],"prefix":"10.1097","volume":"23","author":[{"given":"Sehyo","family":"Yune","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kee-Taek","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Min","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.2001.19.9.2370","article-title":"High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLHQS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694S9512C509801.","volume":"19","author":"Kirkwood","year":"2001","journal-title":"J Clin Oncol"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/1078-0432.CCR-1103-3","article-title":"A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma.","volume":"10","author":"Kirkwood","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system.","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1200\/JCO.2005.05.2498","article-title":"Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses.","volume":"24","author":"Moschos","year":"2006","journal-title":"J Clin Oncol"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1359-6101(01)00022-3","article-title":"Interferon-alpha in tumor immunity and immunotherapy.","volume":"13","author":"Belardelli","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/RLU.0b013e318203bea5","article-title":"F-18 FDG PET positive hilar and mediastinal lymphadenopathy mimicking metastatic disease in a melanoma patient treated with interferon-alpha-2b.","volume":"36","author":"Kalkanis","year":"2011","journal-title":"Clin Nucl Med"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/RLU.0b013e318148afa5","article-title":"PET positive generalized lymphadenopathy and splenomegaly following interferon-alfa-2b adjuvant therapy for melanoma.","volume":"32","author":"Cone","year":"2007","journal-title":"Clin Nucl Med"},{"key":"R16-12-20210129","first-page":"986","article-title":"Study for frequency and aetiology of lymphadenopathy during combination therapy for chronic hepatitis C (pegylated interferon alpha plus ribavirin) at a tertiary care hospital in Hyderabad.","volume":"61","author":"Hayat","year":"2011","journal-title":"J Pak Med Assoc"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2009.07.005","article-title":"Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells.","volume":"31","author":"Cucak","year":"2009","journal-title":"Immunity"},{"key":"R19-12-20210129","first-page":"469","article-title":"Effect of interferon-alpha-2a on the output of recirculating lymphocytes from single lymph nodes.","volume":"64","author":"Hein","year":"1988","journal-title":"Immunology"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0b013e3283632ca7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:24:27Z","timestamp":1621887867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201308000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e3283632ca7","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}